Global Digital Store – Ebooks and Softwares

Tag: Details

  • Updated WHO Information Note: Ensuring continuity of TB services during the COVID-19 pandemic

    Updated WHO Information Note: Ensuring continuity of TB services during the COVID-19 pandemic

    Geneva. The World Health Organization (WHO) Global TB Programme, along with WHO regional and country offices, has developed an updated information note, in collaboration with stakeholders. This note is intended to assist national TB programmes and health personnel to urgently maintain continuity of essential services for people affected with TB during the COVID-19 pandemic, driven by innovative people-centred approaches, as well as maximizing joint support to tackle both diseases. It is important that the progress made in TB prevention and care is not reversed by the COVID19 pandemic. Finding and treating people with TB remain the fundamental pillars of TB prevention and care and those would require maintained attention. This updated note has additional details on clinical management considerations to manage TB and COVID-19, as well as new information on testing.

    Updated WHO Information Note: Ensuring continuity of TB services during the COVID-19 pandemic
    Read More
    https://www.who.int/news-room/detail/04-04-2020-updated-who-information-note-ensuring-continuity-of-tb-services-during-the-covid-19-pandemic

    Views: 0

  • Coronavirus latest: US hospitals come under increasing strain

    The newest coronavirus information up to date day-after-day together with coronavirus instances, the newest information, options and interviews from New Scientist and important details about the covid-19 pandemic
    Coronavirus latest: US hospitals come under increasing strain
    Read More
    https://www.newscientist.com/article/2237475-coronavirus-latest-us-hospitals-come-under-increasing-strain/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home

    Views: 0

  • Medical Product Alert N°3/2020

    This Medical Product Alert warns consumers, healthcare professionals, and health authorities against a growing number of falsified medical products that claim to prevent, detect, treat or cure COVID-19. 

    The Coronavirus disease (COVID-19) pandemic (caused by the virus SARS-CoV-2) has increased demand for medicines, vaccines, diagnostics and reagents, all related to COVID-19, creating an opportunity for ill-intended persons to distribute falsified medical products 

    Due diligence is required from all actors in the procurement, use and administration of medical products, in particular those affected by the current crisis of, or related to, COVID-19. 

    1. FALSIFIED IN VITRO DIAGNOSTICS AND LABORATORY REAGENTS 

    WHO has received multiple reports regarding falsified in vitro diagnostics (IVDs) and laboratory reagents for the detection of SARS-CoV-2. Please refer to WHO’s Emergency Use Listing for a list of diagnostics approved for clinical use by WHO. To date, eight countries (Australia, Brazil, Canada, PR China, Russian Federation, Singapore, Republic of Korea, United States of America) have listed IVDs for COVID-19 diagnosis based on expedited regulatory assessments. Please note that, in the European Union, regulatory compliance for SARS-CoV-2 diagnostics are self-declared by the manufacturer.  

    To assist Member States and stakeholders, WHO has published the links to these emergency lists, together with contact details. These links provide information on IVDs authorized for use in the jurisdictions of the International Medical Device Regulators Forum, as well as policies and guidance. WHO will provide updated versions as new information becomes available.

    End-users are encouraged to check the labelling against the information posted by regulatory authorities upon listing to ensure they are in possession of the genuine product. This information might include product name, product code, expiry date, instructions for use and manufacturer details. 

    Unregulated websites supplying medicines and/or vaccines, particularly those concealing their physical address or landline telephone number, are frequently the source of unlicensed, substandard and falsified medical products. WHO has been made aware of various unregistered websites claiming that products on sale can treat or prevent COVID-19. Such products are likely to be falsified medicines. In addition, some websites may appear to provide easy access to legitimate medicines that are otherwise not readily available. End-buyers and consumers should be especially wary of such online scams and exert due diligence when purchasing any medical product, whether online or not.

     2. FALSIFIED MEDICINES AND VACCINES

    At this stage, WHO does not recommend any medicines to treat or cure COVID-19. However, the SOLIDARITY trial, led by WHO, is reviewing potential treatments for COVID-19. 

    WHO requests increased vigilance from national health authorities, healthcare professionals, members of the public and supply chain stakeholders worldwide to prevent the distribution of these falsified medical products. Increased vigilance should focus on hospitals, clinics, health centres, clinical laboratories, wholesalers, distributors, pharmacies and any other suppliers of medical products. All medical products must be obtained from authentic and reliable sources. Their authenticity and condition of the product should be carefully checked. Consumers are advised to seek advice from a healthcare professional in case of doubt. 

    National health authorities are requested to immediately notify WHO if these falsified products are discovered in their country. If you have any information concerning the manufacture, distribution, or supply of these products, please contact rapidalert@who.int

    WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products
    For further information, please visit our website: https://www.who.int/medicines/regulation/ssffc/en/ 

    Read More
    https://www.who.int/news-room/detail/31-03-2020-medical-product-alert-n-3-2020

    Views: 0

  • Medical Product Alert N°2/2020

    Medical Product Alert N°2/2020

    This Medical Product Alert relates to a confirmed falsified human immunodeficiency virus (HIV) in vitro diagnostic medical device (IVD) that has been identified circulating in Guyana and Kenya.

    Through its Global Surveillance and Monitoring System (GSMS) for substandard/falsified medical products,
    WHO was informed that at least 8,240 falsified rapid diagnostic tests to detect HIV-1/2 have been distributed in Guyana at end-user level. The product is Uni-Gold™ HIV and claims to be manufactured by
    Trinity Biotech plc. Subsequent reports
    revealed that the same falsified product is also circulating in Kenya.

    Uni-Gold™ HIV is a single-use rapid diagnostic test – an immunoassay for the qualitative detection of antibodies to HIV-1 and HIV-2 in serum, plasma and whole blood. Uni-Gold™ HIV is intended for use in point of care settings as an aid
    in diagnosis of HIV-1 and HIV-2 infection.

    The WHO testing strategy recommends three HIV reactive test results to confirm an HIV-positive status in a
    patient. The use of this falsified Uni-Gold™ HIV, subject of WHO medical product alert n°2 of 2020, is likely to lead to delayed diagnosis of HIV status.

    Table 1: Specific details of the falsified product Uni-Gold™ HIV, subject of WHO Medical Product Alert n°2 of 2020

    Product Name

    Uni-Gold™ HIV

    Lot Number

    HIV7120026

    Expiry Date

    5 DEC 2020

    Stated manufacturer

    Trinity Biotech

    The packaging of this falsified HIV test kit is in English.

    The genuine manufacturer (Trinity Biotech plc) has confirmed that:

    • They did not manufacture the falsified product in Table 1.
    • Genuine lot HIV7120026 was made by Trinity Biotech plc and expired in 2019.
    • The expiry date is incorrect and does not correspond with their batch manufacturing records.

    Photographs and advice to the public are available below.

    Figure 1 – Falsified Uni-Gold™ HIV, lot number HIV7120026, displaying falsified expiry date

     

    Falsified UniGold HIV Images 1 and 2 Alert

    Figure 2 – Falsified Uni-Gold™ HIV, displaying labelling inconsistencies

    Falsified UniGold HIV Image 3 Alert

     

    Advice on action to be taken by end-users:

    • Please check to see if any Uni-Gold™ HIV test kits in your facility have lot number HIV7120026.
    • If you are in possession of these falsified test kits with lot number HIV7120026:
    1. Please do not use.
    2. Please immediately contact the organization that supplied you with the product (either your HIV testing programme, nongovernmental organization or local distributor).
    3. Please contact Trinity Biotech plc

    Phone : +353 1 276 9800

    E-mail : hiv@trinitybiotech.com

    1. Please contact your national health authorities

    All medical products must be obtained from authentic and reliable sources. Their authenticity and condition should be carefully checked.

    Advice on action to be taken by national health authorities:

    WHO requests increased scrutiny within the supply chains of all countries, particularly at testing sites (health facilities, community-based), clinical laboratories, medical stores/warehouses, and at the facilities of relevant economic operators (agents,
    authorized representatives, distributors, wholesalers, etc.).

    If these falsified test kits with lot number HIV7120026 are discovered, please do not use.

    National health authorities are asked to immediately inform WHO, if these falsified products are discovered in their country using the WHO IVD complaint form.

    If you have any information concerning the manufacture, distribution, or supply of this product, please contact rapidalert@who.int

     

    WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products

    For further information, please visit our website: https://www.who.int/medicines/regulation/ssffc/en/ 
     

    Medical Product Alert N°2/2020
    Read More
    https://www.who.int/news-room/detail/27-03-2020-medical-product-alert-n-2-2020

    Views: 0

  • Summary of Canada’s Anti-Spam Law

    The status of the recently introduced Canada’s Anti-Spam Legislation (CASL) has been under the limelight for sometime now. It does not seem likely that this law will come into force until late 2013, until all the operational details are made official. Meanwhile, it’s important to understand the recent developments, the progress made by the CRTC (Canada Radio-Television Telecommunications Commission), and the steps to be taken before the law is made official…

    Read More
    http://www.associationofmarketing.org/articles/view.php?article_id=7540

    Views: 0

  • Motac to introduce new campaign to replace VM2020

    Motac to introduce new campaign to replace VM2020

    Motac to introduce new campaign to replace VM2020 1

    KUALA LUMPUR: The Ministry of Tourism, Arts and Culture (Motac) will introduce a new campaign to replace the Visit Malaysia 2020 (VM2020) campaign, which was cancelled following the Covid-19 situation.

    Minister Datuk Seri Nancy Shukri said the long-term campaign would capitalise on the ‘Malaysia, Truly Asia’ brand while highlighting the country’s unique experiences.

    “Motac is confident that this effort will strengthen the country’s competitiveness and sustainability in tourism while ensuring the industry is inclusive,“ she said in a statement today.

    On March 18, Nancy announced the immediate cancellation of VM2020 to prevent the spread of Covid-19, in addition to the impact of the outbreak, which had affected the local and international tourism sector.

    Following the Covid-19 outbreak, Nancy said tourism industry players such as hoteliers, travel agents as well as food and beverage businesses suffered an estimated losses of RM9 billion in the first quarter of the year.

    As such she said, after discussing with the industry players on March 17, it was decided that a strategic action plan should be introduced.

    “Motac has put in place an action plan to help revitalise the industry and ensure the well-being of Malaysians whose livelihoods depend on this industry.

    “Among those present were representatives of the associations from the hotel and tourism industry, bus operators, traders, tour guides and taxi drivers. The meeting was organised by the Tourism Recovery Action Council (TRAC),“ she added.

    Nancy said Motac would discuss with the Ministry of Finance and related agencies, in looking into details tabled by the tourism industry players especially on the forms of assistance that could be channeled to the industry. – Bernama

    Motac to introduce new campaign to replace VM2020
    Read More
    https://www.thesundaily.my/local/motac-to-introduce-new-campaign-to-replace-vm2020-NX2176593

    Views: 0

  • UK’s scientific advice on coronavirus is a cause for concern

    UK’s scientific advice on coronavirus is a cause for concern

    The UK government has published details of the scientific advice behind its strategies to tackle the covid-19 outbreak, but outside experts say it is missing key points and hasn’t been implemented properly
    UK's scientific advice on coronavirus is a cause for concern
    Read More
    https://www.newscientist.com/article/2238186-uks-scientific-advice-on-coronavirus-is-a-cause-for-concern/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home

    Views: 0

  • Google Analytics: The Top 3 Metrics Every Marketer Should Measure

    Growing competition has made it necessary for businesses to be available to their customers all the time. Official websites of the company are one of the most preferred ways in which consumers choose to connect with businesses. This makes it essential for businesses and marketers to understand how exactly their customers use their website and what it is that they are looking for. Getting into these details can help them to a great extent in improving their online presence as well as coming out with online marketing campaigns…

    Read More
    http://www.associationofmarketing.org/articles/view.php?article_id=14160

    Views: 0

  • No 401(k) at work? Here’s how you can save for retirement.

    No 401(k) at work? Here’s how you can save for retirement.

    See details about the retirement options, including some if you’re self-employed.
    No 401(k) at work? Here’s how you can save for retirement.
    Read More
    https://investornews.vanguard/no-401k-at-work-heres-how-you-can-save-for-retirement/

    Views: 0